Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady MED Q1 2026 Earnings EPS Surpasses Estimates Amid Cost Management Efforts ERIE Q1 2026 Earnings EPS Misses Estimates Shares Dip FBRX Q1 2026 Earnings WiderthanExpected Loss Reflects PreRevenue Biotech Reality PRH Q1 2026 Earnings EPS Surges 154 Above Estimates Positive Market Response SILO Q4 2023 Earnings EPS Misses Estimates as Biotech Firm Reports Wider Than Expected Loss